Conference Description
The Cardiac Arrhythmia Mechanisms GRC is a premier, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research, prioritizing time for discussion after each talk and fostering informal interactions among scientists of all career stages. The conference program includes an array of speakers and discussion leaders from institutions and organizations worldwide, concentrating on the latest developments in the field. The conference is five days long and held in a remote location to increase the sense of camaraderie and create scientific communities, with lasting collaborations and friendships. In addition to premier talks, the conference has designated time for poster sessions from individuals of all career stages, and afternoon free time and communal meals allow for informal networking opportunities with leaders in the field.
Heart disease remains a leading cause of morbidity and mortality worldwide and is a major driver of adverse outcomes including cardiac arrhythmias, sudden cardiac death, and stroke. Reflecting this broad clinical and biological challenge, the theme of the 2027 Gordon Research Conference on Cardiac Arrhythmia Mechanisms is Innovating Preventive and Precision Medicine for Heart Disease in Development Through Aging. The primary goal of the conference is to convene clinicians and researchers with diverse scientific perspectives and expertise to advance prevention, risk stratification, and treatment of heart disease across the lifespan, with particular emphasis on the mechanisms by which heart disease predisposes to arrhythmias. The program will address major determinants of heart disease, including cardiometabolic disorders, inflammation and ageing, substance use, and cardiovascular toxicity arising as side effects of other therapies, while also highlighting pregnancy and early childhood as critical developmental periods that influence lifelong cardiovascular health and susceptibility to arrhythmia. In parallel, the conference will explore how emerging technologies – including artificial intelligence, digital diagnostics, pharmaceutical therapeutics, wearables, and implantable loop recorders – can advance precision medicine by improving risk assessment and enabling earlier identification and prevention of heart disease and its arrhythmic manifestations. Building on the success of this conference since its inception in 2003, the 2027 meeting will continue to bring together international leaders and early-career scientists dedicated to understanding and treating heart disease and its rhythm disorders.
The conference chair is currently developing their preliminary program, which will include 9 sessions and the names of the invited speakers and discussion leaders for each of these sessions. The preliminary program will be available by June 17, 2026. Please check back for updates.
